Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Zanamivir MeSH Descriptor Data 2025


MeSH Heading
Zanamivir
Tree Number(s)
D02.078.370.926
D02.241.081.844.562.668.775
D02.241.511.902.562.668.775
D03.383.663.859
D09.067.687.668.775
D09.811.589.668.775
Unique ID
D053243
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D053243
Scope Note
A guanido-neuraminic acid that is used to inhibit NEURAMINIDASE.
Entry Term(s)
2,3-Didehydro-2,4-Dideoxy-4-Guanidino-N-Acetyl-D-Neuraminic Acid
2,3-Didehydro-2,4-Dideoxy-4-Guanidinyl-N-Acetylneuraminic Acid
4-Guanidino-2,4-Dideoxy-2,3-Didehydro-N-Acetylneuraminic Acid
4-Guanidino-2-Deoxy-2,3-Didehydro-N-Acetylneuraminic Acid
4-Guanidino-Neu5Ac2en
5-Acetylamino-2,6-Anhydro-4-Guanidino-3,4,5-Trideoxy-D-Galacto-Non-Enoic Acid
GG 167
GG-167
GG167
Relenza
Pharm Action
Antiviral Agents
Enzyme Inhibitors
Registry Numbers
L6O3XI777I
0
Related Numbers
139110-80-8
CAS Type 1 Name
5-acetylamino-4-guanidino-6-(1,2,3-trihydroxypropyl)-5,6-dihydro-4H-pyran-2-carboxylic acid
Public MeSH Note
2007; ZANAMIVIR was indexed under SIALIC ACIDS (1998-2006)
History Note
2007
Date Established
2007/01/01
Date of Entry
2006/07/05
Revision Date
2017/05/24
Zanamivir Preferred
GG 167 Narrower
Relenza Narrower
page delivered in 0.135s